Navigation Links
U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Date:8/22/2007

Researchers from the University of Minnesota Medical School and Brain Sciences Center at the Minneapolis VA Medical Center have identified a noninvasive and painless way to diagnose complex brain diseases. And its as simple as staring at a point of light. The research offers promise for a less-stressful, painless, and objective diagnosis for brain diseases, as well as a way to measure the effectiveness of different treatments for these diseases. Using magnetoencephalography (MEG) to record tiny magnetic fields in the brain, the researchers recorded brain cells communicating with each other while research subjects stared at a point of light.

After applying various mathematic algorithms, the researchers were able to classify the 142 research subjects by diagnosis. Study participants fell into one of six categories, including people with Alzheimers disease, chronic alcoholism, schizophrenia, multiple sclerosis or Sjogrens syndrome, as well as healthy controls.

The research, led by Apostolos P. Georgopoulos, M.D., Ph.D., professor of neuroscience, neurology, and psychiatry, will be published in the Aug. 27, 2007 issue of the Journal of Neural Engineering. This elegantly simple test allows us to glimpse into the brain as it is working, Georgopoulos said. We were able to classify, with 100 percent accuracy, the various disease groups represented in the group of research subjects. There are no good tests that measure the brain as it functions. Several tests exist to assess brain structure, but they reveal little of how the brain interacts. Currently, brain-related diseases are diagnosed with a combination of behavioral exams, psychiatric interviews, and neuropsychological testing, all which take time and can be hard on the patient, Georgopoulos said. This discovery gives scientists and physicians another tool to assess peoples disease progression, he said. In the future it could be applied when studying the effect of new treatments or drug therapie
'/>"/>
Contact: Sara E. Buss
buss@umn.edu
612-626-7037
University of Minnesota
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Minnesota researchers take new look at cellular suicide
2. Researchers discover way to make cells in the eye sensitive to light
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. NYU researchers simulate molecular biological clock
6. Researchers reveal the infectious impact of salmon farms on wild salmon
7. Researchers identify target for cancer drugs
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Researchers discover molecule that causes secondary stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:2/5/2015)... JOLLA, Calif. , Jan. 30, 2015  It ... the great power and potential for genomic science as ... aid in disease prevention and treatment.  I was honored ... potential new, government-funded precision medicine program. ... advancing the science of genomics—from the first sequenced genome ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... North Carolina State University researcher has shown that water-gel-based ... solar cells to produce electricity. The findings prove the ... nature. They also have the potential to be less ... silicon-based solar cells. The bendable devices are composed ...
... , This release is available in Spanish ... a popular native Hawaiian fruit, has been released by U.S. ... cooperators. ,Ōhelo ( Vaccinium reticulatum Smith ) is ... found at high elevations on the islands of Maui and ...
... an effective vaccine for malaria is a step closer following ... to infect human cells. The discovery, by researchers at The ... new vaccine target through which infection with the deadly disease ... people contract malaria, and more than one million, mostly children, ...
Cached Biology News:Mimicking nature, water-based 'artificial leaf' produces electricity 2Scientists release first cultivated ohelo berry for Hawaii 2Malaria's newest pathway into human cells identified 2
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Gene Therapy - ... , Gene therapy technologies are ... and cell therapy with genetically modified vectors. Gene ... and various routes of administration as well as ...
(Date:3/3/2015)... , March 3, 2015 ... with tools for implementing competency-based training to comply with ... DirectCourse is offering a new crosswalk tool ... (HCBS) implement competency-based training for direct service workers as ... & Medicaid Services (CMS) regulations. CMS amended ...
(Date:3/3/2015)... Md. , March 3, 2015  Synthetic Biologics, Inc. ... infections and diseases, with a focus on protecting the microbiome, ... is scheduled to present at the 27th Annual ROTH Conference ... Laguna Niguel in Dana Point, ... Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
(Date:3/3/2015)... 3, 2015  PDL BioPharma, Inc. (PDL or the ... the third of three shareholder lawsuits filed in the ... On February 2, 2015, a securities lawsuit that ... of a putative class of purchasers of the Company,s ... 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily dismissed without prejudice.  Shortly ...
Breaking Biology Technology:Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... Quintiles,Transnational Corp. today announced the appointment of ... Troullis had been,acting CFO since former CFO John ... Troullis joined Quintiles in 1992 as Director ... CFO, Troullis was Senior Vice President and,Worldwide Controller. ...
... Offer Regulatory ... Operations Expertise, WHIPPANY, N.J., Aug. ... services to streamline the drug,development lifecycle, today announced the expansion of ... Diego. The announcements,illustrate the company,s newly elevated focus on emerging West ...
... at the 58th Annual Meeting of ... (AASLD), TAMPA, Fla., Aug. 15 Romark Laboratories ... of Alinia(R) (nitazoxanide) for,treating chronic hepatitis C in the ... evaluate the effectiveness and safety,of Alinia tablets administered in ...
Cached Biology Technology:ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 2ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 3ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 4Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 2Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 3Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 4
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
BACE (CT) rabbit polyclonal antibody...
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
Biology Products: